SCHEMBL27403233

SCHEMBL27403233

COCc1ccc(F)c(F)c1C(C)(C)C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 2/20 0.40
PRKCE Q02156 1/20 0.36
AKR1C3 P42330 2/20 0.36
AKR1C2 P52895 2/20 0.36
CES2 O00748 1/20 0.34
CES1 P23141 1/20 0.34
MGLL Q99685 1/20 0.34
RET P07949 2/20 0.33
ALKBH1 Q13686 1/20 0.33
MEP1B Q16820 1/20 0.33
APP P05067 1/20 0.33
LTB4R Q15722 1/20 0.32
LTB4R2 Q9NPC1 1/20 0.32
POLB P06746 2/20 0.32
PTGDR Q13258 2/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
PDK2 Q15119 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22655993 0.77 CES2 (0.45) RIPK1AKR1C3AKR1C2CES2CES1
SCHEMBL31691805 0.77 CES2 (0.45) RIPK1AKR1C3AKR1C2CES2CES1
SCHEMBL27403256 0.77 HTT (0.46) AKR1C3AKR1C2CES2CES1L3MBTL1
SCHEMBL19859415 0.71 GCGR (0.36) RIPK1PRKCECES2CES1MEP1B
SCHEMBL18722844 0.69 PRKCE (0.34) PRKCETDP1PDK2
SCHEMBL19859261 0.69 PRKCE (0.34) PRKCEMEP1BTDP1PDK2
SCHEMBL582370 0.68 RET (0.44) PRKCERETPOLBTDP1L3MBTL1
SCHEMBL20333718 0.68 RIPK1 (0.43) RIPK1AKR1C3AKR1C2CES2CES1
SCHEMBL19859156 0.67 CYP3A4 (0.36) PRKCEMEP1BPOLBTDP1
SCHEMBL12585680 0.66 CES2 (0.43) RIPK1AKR1C3AKR1C2CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024145245-A2 ALPHA-V-BETA-8 INTEGRIN INHIBITORS AND USES THEREOF PLIANT THERAPEUTICS, INC. (US) 2024-07-04 WO disclosed